Cordarone

By L. Kulak. Bluefield State College. 2019.

Its first use is in irritable bladder buy discount cordarone 100mg, with deposits of uric acid or triple phosphates; in either case its use will prove beneficial order 100mg cordarone free shipping. Its second use is in irritation of the sympathetic and spinal system of nerves order cordarone 100 mg online, with uric acid deposits buy discount cordarone 100 mg on line. Its third use is as a stimulant to the brain in cases of exhaustion, with phosphuria. I have used it in this case, alternated with a preparation of phosphorus - either the phosphoretted oil or the tincture - with advantage. These are usually cases of exhaustion from over-exertion of the mind, as frequently met with among our business men. Recently benzoate of soda has been recommended by German physicians as a specific in phthisis pulmonalis - the remedy in solution to be used with an atomizing apparatus. Later reports contradict the asserted curative influence, and the results in this country have not been satisfactory. I am inclined to believe that it will be found a good remedy in nephritis and albuminuria, the tongue being pallid. It is indicated by deep-seated pains in the loins, pain in the small of the back, uneasiness in the bladder, with frequent desire to pass urine, and deposits of uric acid. Will some of our Eastern practitioners give us their experience with this agent; or if it has not been employed alone, will some one test it thoroughly. Evidently it has an influence upon the gastro-intestinal mucous membrane, and probably on associate viscera. The subnitrate in doses of from one to two grains; the liquor Bismuth (solution of citrate of bismuth), in doses of from gtt. The first use of Bismuth is to allay irritation of the gastrointestinal mucous membrane; and for this purpose it has been extensively employed. Usually the sub-nitrate in impalpable powder, is employed in small doses frequently repeated for gastric irritation, and in doses of five to ten grains for intestinal irritation, with diarrhœa. The second may be called its specific use, for chronic gastrointestinal irritation, or dyspepsia with diarrhœa. In inveterate cases, not amenable to other treatment, and of years’ duration, I have had the happiest results. I have omitted to name the common use of Bismuth for water-brash, in some cases of which it is very effectual. The powdered sub-nitrate is also a most effectual local application for irritation of the skin - chafing - either in the infant or adult. For this purpose the part is thoroughly dusted, and it is repeated as often as necessary to keep it dry. Reference to the Dispensatory or Materia Medica will give the direction it should take. Boldo leaves are the product of an evergreen shrub in Chili; they are of a reddish-brown color, have a fragrant odor and a pungent aromatic taste. Though largely advertised as a new remedy, it is not likely to take a very prominent place in medicine. It has been recommended and used in anemia, dyspepsia, and nervous debility, the remedy being stimulant to the digestive apparatus and nervous system. We employ a solution of Borax as an antiseptic dressing in wounds, injuries, and surgical operations, the strength being from ʒj. Bromine is not employed as an internal remedy, though its salts have been used largely within the last ten years. It may be employed with advantage as an inhalation in croup and diphtheria, and as a stimulant in phthisis. When I commenced practice it was only used in cases of spermatorrhœa to relieve sexual irritation - now it is recommended for every nervous ill that flesh is heir to. I think it has one specific use, and that is as a remedy for epilepsy when associated with irritation of the reproductive organs, or especially in irritation of the cerebellum. I only use it in spermatorrhœa, in those cases in which the person is of a plethoric habit, with great venereal excitement - cases approximating satyriasis, rather than spermatorrhœa. The most marked symptom indicating its use, that I have noticed, is a dusky flushing of the cheeks, especially over the right malar. Pain in the right side of the face and head, burning in eyes and nose, with acrid nasal discharge. With the first symptom named I should prescribe it in any form of disease, though it is used most frequently in rheumatism, pneumonia and catarrhal affections. If in disease the person has a short cough, or makes an effort to free the lungs, no disease of air passages being present, we would think of Bryonia. So if there is pain in serous membranes, or pain simulating this, the remedy is suggested: thus in rheumatism involving the synovial membranes we would be likely to prescribe this remedy. It may be employed in chronic menorrhagia where the menstrual discharge occurs too frequently or continues too long, or when the discharge is almost constant but colorless. In does not seem to increase or depress innervation, (neither stimulant nor sedative), but rather to influence a regular performance of function. I am satisfied, however, that its continued use improves the nutrition of the heart, thus permanently strengthening the organ. It exerts a direct influence upon the circulation and nutrition of the brain, and may thus be employed with advantage in some diseases of this organ. The cardiac nerves are derived from the upper part of the sympathetic, and, judging from the anatomy of the part, the first cervical ganglion being the principal nervous mass in the cervical region, must furnish innervation through the cardiac nerves, as it certainly controls the circulation and nutrition of the brain. The Cactus is a specific in heart disease, in that it gives strength and regularity to the innervation of the organ. Its influence is permanent, in that it influences the waste and nutrition of the heart, increasing its strength. It exerts no influence upon the inflammatory process, and hence is not a remedy for inflammatory disease. Feelings of weight and pressure at the præcordia, difficult breathing, fear of impending danger, etc. Such irregularity of action, whether violent, feeble, or irregular, as is dependent upon the innervation, is readily controlled. Thus, in the majority of cases of functional heart disease, it gives prompt relief, and, if continued, will effect a cure. In those cases in which there is another lesion acting as a cause, as in some gastric, enteric, or uterine lesions, these must receive attention, and be removed to make the cure radical. In structural heart disease, the first use of remedies is to relieve the distressing sensations in the region of the heart, and the unnatural fear of danger which attends them. As we have seen above, its continuance favors normal waste and nutrition, as well as regular action. Hence, its continued use is followed by the removal of adventitious tissue, and an increase in the strength of its contractile fibre. I have some cases on my case-book of such aggravated form that no one would believe they could live a twelvemonth; yet, after a lapse of five years, they are enjoying comfortable health. But it will not relieve or cure cases of valvular deficiency, dilatation of the openings of the heart, or fatty degeneration. In its influence upon the nervous system, it more nearly resembles Pulsatilla; giving relief in that condition known as nervousness. But further than this, it gives regularity of cerebral function, and permanently improves nutrition of the nervous centers. As a collyrium it may be used of the strength of one to two grains to the ounce of water; as a wash in otorrhœa, and as an injection in gleet, the strength may be five grains to the ounce of water. As an internal remedy I would employ a solution of one grain to sixteen ounces of water, of which the dose would be a teaspoonful. It would be indicated by nausea, vomiting, colic, giddiness, feeble pulse and respiration; mental anxiety would be a prominent symptom. It has been employed as a remedy in dropsy, the dose being larger than the one named. It is especially recommended to be employed in this way in typhoid fever, the discharges from the bowels carrying the germs of the disease.

Usually generic 100 mg cordarone otc, this translates into drugs with effective plasma concentrations in the ng mL−1 (or lower) range discount 100mg cordarone with visa. Even if the drug is sufficiently potent purchase cordarone 200mg on-line, it must yet satisfy other criteria to be considered a viable candidate for transdermal delivery generic cordarone 200 mg overnight delivery. First, its physicochemical properties must allow it to be absorbed percutaneously. This means that its molecular weight should be reasonable (see above), and that it should have adequate solubility in both lipophilic and aqueous environments since, to reach the dermal microcirculation and gain access to the systemic circulation, the molecule must cross the stratum corneum (a lipoidal barrier) and then transfer through the much-more-aqueous-in-nature viable epidermis and upper dermis. Absence of either oil or water solubility will preclude permeation at a useful rate. Second, the pharmacokinetic and pharmacodynamic characteristics of the drug must be such that the relatively sustained and slow input provided by transdermal delivery makes sense. Tolerance-inducing compounds, for example, are not an intelligent choice for this mode of administration unless an appropriate “wash-out” period is programmed into the dosing regimen (see the discussion of nitroglycerin below). Drugs with short biological half-lives, that are subject to large first-pass metabolism, necessitating inconvenient and frequent oral or parenteral dosing (with the concomitant problems of side-effects and poor compliance), are good candidates. On the other hand, drugs that can be given orally once a day, with reproducible bioavailability, and which are well tolerated by the patient, do not really need a patch formulation. Third, the drug must not be locally irritating or sensitizing, since provocation of significant skin reactions beneath a transdermal delivery system will most likely prevent its regulatory approval. Although of demonstrated efficacy, these vehicles are often inelegant and result in poor reproducibility of the delivered dose (and hence of the provoked pharmacological effect). This variability, of course, originates in the 199 application procedure: the amount of formulation applied, the area to which it is applied, the amount of inunction used, and the potential for subsequent depletion to clothing, etc. There is a concern, furthermore, about the inadvertent transfer of material from the treated individual to another person via bodily contact. On the other hand, these conventional delivery systems are relatively simple and inexpensive to manufacture. All of these drugs are extremely potent, none requiring more than about 20 mg per day (and some, much less) for effective therapy. These patches are diversely referred to as “reservoir”, “monolithic”, “membrane-controlled”, “adhesive”, “matrix”, and so on. Unfortunately, these terms are not always used consistently and, worse, they are sometimes used inaccurately. In all cases, however, the idea is that the system offers a means to hold a “payload” of the drug and a configuration (or “platform”) to ensure presentation of the active agent to the skin surface at a rate sufficient to ensure a systemic pharmacological effect after the drug has crossed the skin’s barrier. Most simplistically, one can divide the transdermal formulations presently available into three categories (Figure 8. Upon removal from their package, all these devices present common exterior surfaces. On one side, they have an impermeable backing layer across which neither the drug nor any other component can diffuse. On the other face which will contact the skin, there is a peel strip which is removed prior to application. In between these two layers, however, the composition and design of the device varies considerably. Adhesive patches The adhesive patches are simplest in concept, consisting only of a layer of drug-containing adhesive polymer which serves, therefore, as a reservoir of the compound and the means by which the device is held to the skin. These systems can hold substantial amounts of the active agent, often in considerable excess of that delivered during the designated application of the patch (e. Not infrequently, the degree of control offered by these systems is relatively small (see below), and it is the stratum corneum that ultimately regulates the absorption rate of the drug into the body. It should be noted that these representations of the patches greatly exaggerate their real thicknesses, which are in fact similar to that of a normal Band-Aid The layered devices are a little more complex than the simple adhesive systems in that they use different polymer compositions or different polymers to provide the functions of drug-containing matrix and adhesive. It should also be noted that some layered systems have been developed in which the drug-containing matrix contacts the skin directly and the patch is held to the skin by a peripheral adhesive. While effective, these devices suffer from the drawback that the area of contact between patch and skin is significantly greater than the “active” area, i. These devices are characterized by two particular features: first, an enclosed reservoir of the drug, which may be liquid in nature; and, second, a polymeric membrane separating the reservoir from the adhesive layer, itself made from a different polymer. The idea, naturally, behind this design is that the membrane acts as a rate-controlling element for drug delivery to and across the skin (i. There are, in fact, situations for which this claim is true; however, it must also be noted that there are others where the control lies, at least in part, elsewhere (see below). The essential components of a transdermal system are the drug, one or more polymers, the “vehicle”, and other excipient(s). Polymers are used in transdermals as pressure-sensitive adhesives, release liners, backings and laminates, and for speciality films and supports. A pressure-sensitive adhesive may be defined as a solvent-free, permanently tacky, viscoelastic substance, capable of adhering instantaneously to most solid surfaces with application of slight pressure, and removable without leaving perceptible residue. Release liners are usually silicone and fluorocarbon coatings on paper, polyester or polycarbonate films. Backing and other membranes are fabricated with diverse polymers including ethylene vinyl acetate, polypropylene, polyester, polyethylene, polyisobutylene and polyvinyl chloride. Special films in current use include foams, non- wovens, micro-porous membranes, etc. Additional excipients, present for stability and other purposes, may be lactose, silicon dioxide, cross-linking agents, and hydroxyethylcellulose. The manufacture of a transdermal drug delivery system is a complex and sophisticated process requiring specialized equipment and facilities. In the most basic and generic sense, two procedures can be identified, one for “solid-state” patches (adhesive and layered systems), the other for reservoir devices. In the former case, the important steps are: (a) Mixing of drug, excipients, polymers and solvent to make a coating solution (or solutions), (b) Casting the coating solution(s) onto the protective liner, evaporating the solvent, and laminating the backing film, (c) Die-cutting the drug laminate to the desired patch size, (d) Packaging. For reservoir systems, the components of the reservoir (drug, excipients, viscous liquid) are first mixed. Separately, the adhesive polymers and solvent are mixed to make a solution, which is then cast onto a protective liner. The system is then assembled by forming the backing film, pumping in the drug reservoir, and then heat-sealing the laminate to the backing. That is, if the delivery system truly controls the rate of absorption of drug into the body, then only the variability in clearance remains as a factor to influence the resulting plasma concentration achieved (Equation 8. Given, however, that there now exist on the market many different patches for one specific drug, all of which are approved for the same therapeutic indication (and the same delivered dose), it is appropriate to ask to what extent does the control of delivery rest with the patch as opposed to the skin. To illustrate this point, consider three of the presently marketed nitroglycerin systems that are labeled to deliver drug at 0. First of all, it should be noted that, despite the differences in design, drug loading and surface area, these patches are considered to be bioequivalent. Thus, one cannot use drug content nor mechanism of release as useful parameters with which to assess the comparability of different transdermal systems (by contrast, for oral delivery, a generic Table 8. In the first (Experiment A), drug release from the patch directly into 202 Figure 8. In left panel, drug release from the patch into an aqueous receptor is measured (“Experiment A”). In the right panel (“Experiment B”) the transport kinetics are re-assessed when excised skin is interposed between the patch and the receiving medium (Modified from Hadgraft J. In the second (Experiment B), drug release into the same aqueous receptor is again measured, but now the skin is interposed between the patch and the receiver medium. If the patch is perfectly rate- controlling, the rates of appearance of drug into the receptor phase in the two experiments will be identical. On the other hand, if the drug arrives more slowly in Experiment B than in Experiment A, it can be concluded that the skin is playing at least some role in controlling the drug’s flux into the body. The results of these experiments for the three nitroglycerin patches are shown in Figure 8. It is immediately apparent that the release of drug from Nitrodur is much greater in the absence of skin than when skin is present (compare nearly 76 mg released in Experiment A in 24 hours with 10 mg released in Experiment B). By contrast, for Deponit, the amounts reaching the receptor phase in 24 hours in Experiments A and B are quite similar, about 11 and 10 mg, respectively. Transderm-Nitro falls in between, with ~22 mg released in Experiment A, compared to 10 mg in Experiment B.

In some cases we have a first preparatory treatment buy cordarone 200mg without prescription, to fit the patient for the reception of remedies which directly oppose disease buy cordarone 200 mg low price. In other cases there are certain prominent symptoms indicating pathological conditions which may be taken as the key-notes of the treatment 200mg cordarone visa. As generic 200mg cordarone free shipping, when we have the full, open pulse, indicating Veratrum; the hypochondriac fullness, umbilical pains, and sallowness of skin, indicating Nux Vomica; the bright eye, contracted pupil and flushed face, calling for Gelseminum; or the dull eye, immobile pupil tendency to drowsiness, which calls for Belladonna. In some cases the indication for a special remedy, like one of these, is so marked, that we give it alone, and it quickly cures most severe and obstinate diseases. I would like to continue this subject further, for it is one in which I am greatly interested, and I know it is one in which you are interested, but the shortness of our session will not permit further remarks. But when we come together another year, with another year’s experience, we may discuss it again. The practice of medicine is proverbially uncertain, not so much possibly as regards the termination of disease, as regards the influence of medicine to palliate or arrest it. Instead of making this uncertainty a cardinal doctrine, a belief in which is absolutely essential to regularity, it seems to me it would be profitable to examine it carefully, and by analysis determine the “elements of uncertainty;” we might then hope to determine the “elements of certainty,” and by a simple process of reasoning, avoid error and attain truth. The most important factor in “medical uncertainty,” is undoubtedly our present nosology. The element of uncertainty lies here, that a name employed to designate a disease, may cover the most diverse pathological states. The case of to-day, and the case of to-morrow, though justly called by the same name, may require a widely different treatment; the remedies employed successfully in one, would increase the disease in the other. Every one of our readers may draw the evidence of the truth of these propositions from his own practice. The second “element of uncertainty” we find in the doctrine of idiosyncrasy, which is also a cardinal article of faith. We are gravely taught that in medicine one of nature’s laws - that “like causes produce like effects,” is inoperative; and, on the contrary, “that no man can possibly tell from the action of a medicine on one, what will be its influence upon another. The third “element of uncertainty” lies in the application of the Latin motto, post hoc ergo propter hoc - that which follows a medicine must be due to its influence. If a man recovers from sickness after taking Podophyllin or Quinine, it is due to these agents, and he probably would not have gotten well without them. But there is this singular fact here: whilst physicians are willing to credit their remedies with all relief from suffering, improvement and restoration to health, they are not willing to reverse it, and concede increase of suffering, prolongation of disease and death to the remedies, though the sequence is quite as natural in the one case as the other. It does seem strange that physicians should have so thoroughly believed that medicine saved the lives of the sick, that without it the majority, or all, would have died. Even now when all this is proven beyond cavil, by some of the best observers, we find the majority won’t believe it; even if they concede it in theory, they deny it in practice. The fourth element of uncertainty lies in the endeavor to get direct results from indirect agencies. You want to influence the circulation and the temperature, and you give remedies which produce emesis or catharsis. You want to elect Greeley, and you whip your neighbor because he “rah’s” for Grant. The fifth element of uncertainty is the administration of remedies in poisonous instead of medicinal doses. It is true that the poisonous action may be known with some certainty, but its influence upon disease is very uncertain. The poisonous action sets up a new process of disease in so far as it changes structure and function, and it may be curative according to the law of substitution. A medicinal action we understand to be one that restores function, and thus removes disease. Give your remedy in medicinal doses, and then you may expect direct and positive results in the relief of disease. These are the principal elements of uncertainty in regular medicine and in our school. To these we might add a number of minor ones, among which is a belief in “special providences,” inscrutable or otherwise. Indeed any one who is inclined to shift his responsibility upon his Creator, and to believe that the laws of nature can be suspended from any providence, has all the elements of uncertainty with him. The principal element of uncertainty in Homœopathic medicine is the making of pain a principal symptom, and the treatment of symptoms in place of pathological conditions. The cheerful trust in Nature of the high dilutionist is laudable, though we can’t say so much for their claim to all the glory of relief and recovery. This is but a rough sketch of the subject, which we present as good material for thought. In our next article, we will consider the “elements of certainty” in medicine, in the same order. In our last article we briefly discussed the “elements of uncertainty in medicine,” and we now propose to look at the other side - how may we attain certainty in medicine. We all agree that the practice of medicine in the past has been notoriously uncertain, and that there is yet great room for improvement. The first, and most important element of “uncertainty” is found in our present nosology, and the constant tendency to prescribe for names of disease. The first “element of certainty” will be, therefore, an entire avoidance of this error, diagnosing pathological conditions and prescribing for these. We have heretofore seen that disease, as we meet it in the individual, consists of a series of functional lesions - all disease is an impairment of function. Certain prominent lesions or symptoms give a name to the disease, according to the present nosology, but the name does not, and can not convey to the mind the character of the lesions or the treatment required to remove them. If I say my patient has “pneumonia” (taking one of the simplest diseases), I give you no information which would guide you to a correct treatment, and if you prescribe it must be upon the idea that all inflammations of the lung are alike, unless you follow the expectant plan, and use the “mush poultice,” with rest and good nursing. In one case the prominent lesion would be of the circulation and temperature; and we would stop the inflammation by the third day with the use of Veratrum and the bath, alone. In a third class of cases, with especial impairment and feebleness of mucous structure, Ipecac would be a prominent remedy. In a fourth class of cases, with special impairment of skin and dryness of mucous membranes, we would use Asclepias. In a fifth, if we had the broad pallid tongue, we might treat the case with Bicarbonate of Soda alone. In a sixth, of typhoid character, we would obtain especial benefit from Sulphurous Acid, Muriatic Acid, Sulphite of Soda, or Baptisia. In a seventh class of cases, with hypochondriac fullness, umbilical pain, sallowness and puffiness of skin, yellowness about the mouth, and the coloring matter of bile in urine, I will cure every case with the single remedy, Nux Vomica. Eighth, all our readers know that there is a class of cases in which Quinine is eminently curative, and will alone speedily arrest the disease Is it not most absurd, therefore, to talk about a stereotyped treatment of pneumonia? We have named eight classes of cases, and in the entire lot have wanted no remedy for the lungs. It really makes no difference whether it is an inflammation of the lungs or the nates, only in so much as a man breathes with the one and sits on the other. We want to know the character of the lesion of the circulation, the temperature, the functions of digestion, nutrition, secretion and excretion innervation, etc. The second element of certainty is a firm reliance on nature’s law - “that like causes produce like effects. We want to study those symptoms and signs that determine exact conditions of disease, and then knowing the action of remedies we may always give them with certainty. We study the direct or specific action of remedies by using them singly, and observing the consequences in numerous cases; it is confessedly a work of time, and a work of difficulty, but it can be done. The fourth element of certainty is found in giving remedies for their direct effects, and not as they produce counter-irritation or some other disease. If the circulation is wrong, we give a remedy that acts directly upon the circulatory system, and in such way that the wrong may be righted. If there is a lesion of the blood, we give a remedy that reaches the blood and antagonizes the lesion. If the skin, kidneys or bowels fail to do their work of excretion, we reach them by remedies that exert their influence directly, and so of the entire Materia Medica.

Corticosteroids long have been part of every immunosuppression protocol for every center regardless of the organ transplanted purchase 200mg cordarone with amex. For many liver transplant centers cheap cordarone 100 mg otc, steroids now are being phased out of the protocol because of the deleterious long-term side effects associ- ated with chronic steroid use and the better and stronger immunosup- pression medications now available 100 mg cordarone overnight delivery. This drug blocks proliferation of T and B lymphocytes and inhibits antibody formation and the generation of cytotoxic T cells buy discount cordarone 200 mg online. Instead, doses are lowered when toxicity occurs (usually in the form of diar- rhea or nausea and vomiting). Unfortunately for the pediatric recipient, finding an appropriately sized donor is more dif- ficult, since the pediatric cadaver donor pool is far smaller than the adult cadaver donor pool. In addition, the percentage of cadaveric liver transplants going to pediatric patients decreased from 15% in 1992 to 10% in 2000. Usually this entails taking a small piece of the liver from an adult and placing it into the child. Aprospective randomized trial of tacrolimus and pred- nisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients. Also, as is the case for kidney transplants in chil- dren, a strong social situation is crucial to the long-term success of the transplant process. The social services evaluation is vital to obtaining the pertinent information in order to help with the decision of whether or not a pediatric recipient is a suitable candidate. This entails taking a much bigger piece of the liver, usually the whole right lobe, from the donor and anastomosing it into the recipient. As the technical difficulty of this procedure is great, the mortality and morbidity rates are noted to be as high as 0. As long as the shortage of donor liver organs exists, living donor and other ingenious methods to increase the donor pool will continue to evolve. Graft survival and standard errors at 3 months, 1 year, 3 years, and 5 years; deceased donor liver transplants. Cohorts are transplants performed during 1999–2000 for 3-month and 1-year survival; 1997–1998 for 3-year sur- vival; and 1995–1996 for 5-year survival. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ. Center volume = Center’s yearly transplants performed during the base period, based on liver transplants. The smaller left lateral segment goes into a child or into a small recipient, and the bigger, full-sized right lobe goes into an adult or into a larger recipient. Summary The face of liver transplant continues to evolve as human ingenuity attempts to catch up with the persistent organ shortage. Attempts at xenotransplantation and artificial livers or assist devices still are in progress. Much research has gone into growing hepatocytes to a state that they may someday save a human life, but, to date, this still is a theory and not reality. Stem cell research at this time is still that— research without any practical current use. Currently, with the stagnant growth in the number of cadaver donors, living donation has been the lone bright spot for all of trans- Table 42. Graft survival and standard errors at 3 months, 1 year, 3 years, and 5 years; living donor liver transplants. Cohorts are transplants performed during 1999–2000 for 3-month and 1-year survival; 1997–1998 for 3-year sur- vival; and 1995–1996 for 5-year survival. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ. Center volume = Center’s yearly transplants performed during the base period, based on liver transplants. The improved results of laparoscopic donor nephrectomy have helped to increase the donor pool for the fortunate recipients with living donors. Diagnosis and treatment of biliary tract complications after orthotopic liver transplanation. See Advanced Cardiac etiologic classification for, 411 abscess Life Support vascular, 426–431 breast, 347 Acne, 326 workup of, algorithm for, 482 classified by location, 471 Acquired cysts, 415–416 Abdominal pain, 375–407. See Acute tubular necrosis Barium swallow, 210 443 Atresias, neonate intestinal achalasia and, 226 Biliary obstruction with normal obstruction and, 654–655 esophageal swallowing hepatocyte’s, 437 Atrial septal defect, 271 disorders and, 206 Biliary sepsis, 437 Atypical hyperplasia, 340, 341, Barret’s esophagus, 224–225 Bilirubin metabolism, 444 351 treatment of, medical v. See Basal cell carcinoma Biofeedback, urinary head, hip dislocation Beck’s triad, 291 incontinence and, 663 and, 610 pericardial tamponade and, Biopsy. See Benign prostatic B-lactam ring, 112 Hypertension; hyperplasia Bladder Hypotension Brachial cleft cyst, 182 abnormalities of, 668 monitoring, thoracic aorta Brain, arterial anatomy of, 307 fistula on, 458 and, 300 Brain death Bladder drainage technique pheochromocytoma and, 333 cadaver donor and, 708, 743 enteral drainage technique v. See Coronary artery alcohol consumption and, trauma and, 551 bypass grafting 178–180 Breslow depth, melanoma and, Cadaveric donor(s). See also Collateral 236 Compartment pressure, burn circulation Coarctation of aorta, 328, 330 wounds and, 629 hemodynamically stable vascular etiology of, 333 Compartment syndrome, 589, patient and, 137 Colitis, infectious colitides v. See Platinol anatomy of, 447–449 disease, 328 Clark classification of tumor arterial supply to, 448 Complex lesions, 260 depth, melanoma and, functions of, 448 Compliance, ventilatory modes 536, 538 posterior aspects of, 447 and, 92 Claudication, 501, 502. See also venous drainage of, 449 Complicated gastroesophageal Intermittent Colon cancer. See also Acquired cysts; Congenitally deformed hepatocellular function Congenital cysts bicuspid valve, 269 in cirrhosis breast, 335, 338, 415–416 766 Index Cyst(s) (cont. See Oculocephalic Cystoscopy Diarrhea testing abdominal masses and, 412 diagnosis and management Donor. See Diabetic Control urinary stones and, 676 bladder drainage and Complications Trial Differential diagnosis, 33, 136 technique v. See also Topical drug Detrusor hyperreflexia/ Diuretics, brain volume and, therapy; Specific drugs overactive bladder, 582 i. See Electrocardiogram and, treatment of, Enteral drainage technique Echocardiography 627–630 bladder drainage technique chest pain and, 295 Emergency medical services v. See also burn wounds and, 630 Esophagogastroduodeno- Eversion endarterectomy complications of, 57 scopy stroke and, 317, 321 pediatric patient and, 638 768 Index Enterobacteriaceae bacteria, Esophagectomy with gastric Exposure, trauma and, 554 pyelonephritis and, 677 replacement, esophageal External hemorrhoids, 474–475 Ephelides. See Functional residual Gastrointestinal bleeding, Gluteus maximus, contusion of, capacity 355–373, 373. See also Head of metacarpal, laceration shock states and, Abdominal wall hernias; of, 608–609 differential diagnosis of, Groin hernias; Hiatal Healthcare staff, secondary 131 hernias; Inguinal hernia survey and, 555 Hemolysis, jaundice and, 435 incisional, 495, 496 Heart, compressive cardiogenic Hemoptysis, 233, 234–240 indirect inguinal, 484 shock and, 127 causes of, 234 parastomal, 496 Heart chamber enlargement, diagnostic evaluation for, 236 pelvic floor, 496 chest X-ray and, 273 management of, 238–240 syndromes, 574 Heart murmur, 257–282. See also shock, 87 High dose dexamethasone Acquired disease of Hemorrhagic pancreatitis, 386 suppression test, heart valves; Hemorrhagic shock, physical Cushing’s disease, 329 Congenitally deformed findings in, 121, 356 High energy fracture of pelvis, bicuspid valve Hemorrhoids, 474–475 610 anatomy of, 265–266 differential diagnosis for, 474 High energy lateral competency, acute changes management of, algorithm compression injuries, 611 in, 271 for, 475 Hip joint, 609 prosthesis, types of, 277 Hemostasis, 136–148, 148 dislocations of, 609 replacement, aortic stenosis Heparin, 13. See Human Hyperthermic isolated limb Iliac aneurysms, 386 immunodeficiency perfusion, sarcoma and, Imaging studies. See Surgical intensive care congenital hernias and, 497 hypercalcemia and, 78 unit congestive heart failure in, Hyperphosphatemia, 80 Ileal atresias, neonate and, 645 258–262 Index 773 electrolyte requirements in, Informed consent, 17. See Intravenous L 198 pyelography Laboratory studies Larynx, 193 abdominal pain and, 384–385 cancers of, 192 J acute epididymitis and, 698 parts of, 192 Jaundice, 433–445. See Lower urinary tract 735–737 372–373 symptoms 776 Index Lymphedema, 512, 524–525. See also Melanoma shock and, 87 lymphedema; bloody discharge and, 350 Mechanical obstruction, 402, Elephantiasis; Pneumatic hypercalcemia and, 78 403 compression garments jaundice and, 442 Mechanical valve, 277 treatment for, 525 microcalcifications and, 348, Mechanical ventilation Lymph node(s). See also 349 discontinuation of, 95 Regional lymph nodes neck mass and, 186 pulmonary management hemoptysis and, 236 nevi and, 533 and, 92 lung cancer and, 241 papilloma v. See obstruction and, 653, 654 lymphedema and, 525 Sarcoma Meconium stool, neonate and, Malignant thyroid lesion, oral 649 M thyroid hormone and, Mediastinoscopy, cancer Macrodantin, cystitis and, 666 188 staging and, 248 Macrolide antibiotics, 113 Mallory-Weiss tear, 366 Medical condition, kidney Mafenide acetate (Sulfamylon), gastrointestinal bleeding and, transplantation and, 706 burn wounds and, 628 360 Medical evaluation, surgical Magnesium, 80 Malnutrition, 44 evaluation v. See also atypical nevi and, 534 Maintenance fluid Axillary dissection; disease staging of, 536 calculation of, 641 Breast cancer, early stage evaluation of, 534 estimating, pediatric patient breast conservation v. See Non-small-cell Oculovestibular testing, 566 Nervous system, damage to, lung cancer gaze centers and, 567 589 Nutcracker esophagus, 229–230 Odynophagia, 203 Neurogenic pain, abdominal Nutrition. See Orthotopic liver Neurogenic shock, 121 Nutritional support transplant spinal shock v. See also 642 with, 729–730 Multiple organ Paclitaxel, breast cancer and, 347 postoperative monitoring in, dysfunction system Pain. See Operating room 378 occlusion pressure 780 Index Papillary carcinoma of thyroid, congenital heart disease and, Penicillin, 112 197 260 dirty cases and, 107 Papilloma, malignancy v. See fracture and, 594–595 Penile meatus, hematuria and, Type 2 hiatal hernias gastrointestinal bleeding and, 664 Paralysis, thoracic aorta 359 Pentastarch, 123.

It was one of the first specific cell-mediated immune responses to be identified—as early as the 1940s in guinea pigs buy cordarone 200mg on-line. The test reaction will only develop should continuously activated Tcells be present with- in the host generic cordarone 100mg amex,since only these cells are capable of migrating todermallocations within 24–48 hours discount 100mg cordarone with amex. If no activated Tcells are present buy 200 mg cordarone mastercard, re-activation within the local lymph nodes must first take place, and hence migration into the dermis will require more time. By this time the small amount of introduced diagnostic peptide, or protein, will have been digested or will have decayed and thus will no longer be present at the injection site in the quantity required for induction of a local reaction. A positive delayed hypersensitivity reaction is, therefore, an indicator of the pre- sence of activated T cells. The absence of a reaction indicates either that the host had never been in contact with the antigen, or that the host no longer pos- sesses activated Tcells. In the case of tuberculosis, a negative skin test can indicate that; no more antigen or granuloma tissue is present, or that the systemic immune response is massive and the pathogen is spread throughout the body. In the latter case, the amount of diagnostic protein used is normally insufficient for the attrac- tion of responsive T cells to the site of injection, and as a consequence no measur- able reaction becomes evident (so that the Mantoux test may be negative in Land- ouzy sepsis or miliary tuberculosis). Control of cytopathic viruses requires so- luble factors (antibodies, cytokines), whilst control of noncytopathic viruses Kayser, Medical Microbiology © 2005 Thieme All rights reserved. Usage subject to terms and conditions of license 100 2 Basic Principles of Immunology and tumors is more likely to be mediated via perforins and cytolysis. How- ever, cytotoxic immune responses can also cause disease, especially during noncytopathic infections. Development of an evolutionary balance between infectious agents and immune responses is an ongoing process, as reflected by the numerous mechanisms employed by pathogens and tumors to evade 2 immune-mediated defenses. Natural humoral mechanisms (antibodies, comple- ment, and cytokines) and cellular mechanisms (phagocytes, natural killer cells, T cells) are deployed by the immune system in different relative amounts, during different phases of infection, and in varying combinations. Gross simplifications are not very helpful in the immunological field, but a small number of tenable rules can be defined based on certain model in- fections. Such models are mainly based on experiments carried out in mice, or on clinical experience with immunodeficient patients (Fig. General Rules Applying to Infection Defenses & Non-specific defenses are very important (e. Antibodies are also likely to make a major contribution to the host-parasite balance occur- ring during chronic parasitic infections. Usage subject to terms and conditions of license Immune Defenses against Infection and Tumor Immunity 101 General Schemes of Infectious Diseases 2 Fig. Infection by cytopathic pathogens can only be controlled if pathogenic proliferation is slow and the pathogen remains localized; otherwise the outcome is usually fatal. In the case of noncytopathic pathogens, the cytotoxic T-cell response is the critical parameter. The T-cell response can be halted by pathogens which proliferate rapidly and spread widely due to the deletion of responding Tcells. For pathogens which exhibit moderate rates of proliferation and spread, the T-cell response may cause extensive immunopathological damage, and thus reduce the proportion of surviving hosts, some of which will controll virus, some not. A weakened immune defense system may not progress beyond an unfavorable virus-host balance, even when confronted with a static or slowly replicating patho- gen which represents an initially favorable balance. Although de- tails of the process are still sketchy, IgE-dependent basophil and eosinophil defense mechanisms have been described for model schistosomal infections. Usage subject to terms and conditions of license 102 2 Basic Principles of Immunology & Avoidance strategies. Infectious agents have developed a variety of stra- tegies by which they can sometimes succeed in circumventing or escaping immune responses, often by inhibiting cytokine action. Short-lived IgM responses can control bacteria in the blood effectively, but are usually insufficient in the controlof toxins. In such cases, immunoglobulinsof the IgGclass are more efficient, as a result of their longer half-life and greater facility for diffusing into tissues. Avoidance Mechanisms of Pathogens (with examples) Influence on the complement system. Some pathogens prevent complement fac- tors from binding to their surfaces: & Prevention of C4b binding; herpes virus, smallpox virus. Viruses can avoid confrontation with the immune defenses by restricting their location to peripheral cells and or- gans located outside of lymphoid tissues: & Papilloma viruses; infect keratinocytes. Infection agents can avoid immune defenses by mutating or reducing their expression of T- or B-cell epitopes. Usage subject to terms and conditions of license Immune Defenses against Infection and Tumor Immunity 103 Continued: Avoidance Mechanisms of Pathogens (with examples) Influence on lymphocytes and immunosuppression. Immune Protection and Immunopathology Whether the consequences of an immune response are protective or harmful depends on the balance between infectious spread and the strength of the ensuing immune response. As for most biological systems, the immune de- fense system is optimized to succeed in 50–90% of cases, not for 100% of cases. For example, immune destruction of virus-infested host cells during the eclipse phase of a virus infection represents a potent means of preventing virus replication (Fig. If a noncytopathic virus is not brought under im- mediate control, the primary illness is not severe—however, the delayed cy- totoxic response may then lead to the destruction of very large numbers of infected host cells and thus exacerbate disease (Tables 2. Since an infection with noncytopathic viruses is not in itself life-threatening to the Kayser, Medical Microbiology © 2005 Thieme All rights reserved. Usage subject to terms and conditions of license 104 2 Basic Principles of Immunology Table 2. Auto- “Healthy” or unknown infections, immunity occult carrier viruses, bacteria, (although infec- and endogenous tious agent is retroviruses unknown) Clinical None Chronic Variable disease symptoms disease symptoms, some- times delayed or asymptomatic Kayser, Medical Microbiology © 2005 Thieme All rights reserved. Usage subject to terms and conditions of license Immune Defenses against Infection and Tumor Immunity 105 Table 2. A similar situation is also observed for the cellular immune response against facultative intracellular tuberculosis and leprosy bacilli which themselves have relatively low levels of pathogenicity (Table 2. A healthy immune system will normally bring such infectious agents under control efficiently, and the immunological cell and tissue damage (which oc- curs in parallel with the elimination of the pathogen) will be minimal, en- suring that there is little by wayof pathological or clinical consequence. How- ever, should the immune system allow these agents to spread further, the result will be a chronic immunopathological response and resultant tissue destruction—as seen during hepatitis B as chronic or acute aggressive hepatitis and in leprosy as the tuberculoid form. Should a rapidly spreading infection result in exhaustion of the T cell response, or should an insufficient level of immunity be generated, the infected host will become a carrier. This carrier state, which only occurs during infections characterized by an absent or low- level of cytopathology, is convincingly demonstrated in hepatitis B carriers and sufferers of lepromatous leprosy. Because the im- muneresponse also acts toinhibit virus proliferation, the process of cellulardestruc- tion is generally a gradual process. Paradoxically, the process of immunological cell destruction would helpthevirus survivefor longer periodsin the host and hence facilitate its transmission. From the point of view of the virus this would be an as- tounding, and highly advantageous, strategy—butone with tragic consequences for the host following, in most cases, a lengthy illness. Influence of Prophylactic Immunization on the Immune Defenses Vaccines provide protection from diseases, but in most cases cannot entirely prevent re-infection. Vaccination normally results in a limited infection by an attenuated pathogen, orinduces immunity through the useofkilled patho- gens or toxoids. The former type of vaccine produces a very mild infection or illness capable of inducing an immune response and which subsequently protects the host against re-infection. The successful eradication of smallpox in the seventies so far represents the greatest success story in the history of vaccination. The fact is that vaccinations never offer absolute security, but instead improve the chances of survival by a factor of 100 to 10 000. A special situation applies to infections with noncytopathic agents in which disease results from the immune response itself (see above). Under certain circum- stances, and in a small number of vaccinated persons, the vaccination pro- cedure may therefore shift the balance between immune defense and infec- tion towards an unfavorable outcome, such that the vaccination will actually strengthen the disease. Rare examples of this phenomenon may include the Kayser, Medical Microbiology © 2005 Thieme All rights reserved. Generally, it should be kept in mind that most of the successful immunization programs developed to datehavemediated protectionvia antibodies. This par- 2 ticularly applies to the classic protective vaccines listed inTable 1. This ex- plains why successful vaccines all protect via neutralizing antibodies, because this pathway has been selected by co-evolution. As mentioned earlier, with regard to immunological memory, memory T cells appear to be essential to host immune protection, particularly in those situations when antigen per- sistence is controlled efficiently by means of infection-immunity (e. Tumor Immunity Our knowledge concerning the immune control of tumors is still modest.

He had a hypothesis buy generic cordarone 100 mg online, which could never be verified discount cordarone 100 mg on line, that there was a connection between the appearance of staphylococcal colonies and their pathogenicity buy cordarone 100 mg amex. Among his staphylococcal plates buy 100mg cordarone with visa, on one occasion, Fleming observed a plate with a large patch of mold growing on it (Fig. The staphylococcal colonies on the same plate seemed to maintain a distance from the mold, not growing in its vicinity. A replica of the original plate of Alexander Fleming showing a patch of Penicillium mold and Staphylo- coccus colonies seeming to avoid the mold patch. This phenomenon caught Fleming’s attention, and one of the many biographies about him (Gwyn Macfarlane, Alexander Fleming, The Man and the Myth, The Hogarth Press, London, 1984) describes how on a sunny September morning in 1928 on the lawn outside the laboratory, he showed the plate to two fellow bacteriologists. None of the three could explain the phenomenon on the plate or at all imagine that at that moment they had a tryst with destiny. The interpretation of this phenomenon would open the way for the greatest triumph of scientific medicine: the control of bacterial infections with selectively acting drugs. The diffusible agent inhibiting bacterial growth on the plate in the vicinity of the mold was named penicillin by Flem- ing, and together with its many derivatives, it would eventually become dominant among antibiotics in the treatment of bacterial disease. By its mechanism of action (Chapter 4), penicillin cannot act on resting nondividing bacterial cells—only on growing bacteria. This circumstance, together with the property of mold to grow much more slowly than staphylococci, led to the conclusion that penicillin could not have been discovered in the manner described. If the agar plate was already polluted with mold cells when Fleming streaked it with the staphylococci he was interested in, they would have grown out to be insusceptible to penincillin long before the mold had grown out enough to produce penicillin. The mold could also not have grown out to form a colony before inoculation with bacteria, since no microbiologist would use a contaminated agar plate. This microbiological mystery seems to be explained by a fantastic sequence of coincident circumstances. Fleming seems to have inoculated the agar plate at the end of the month of July and then left for summer holiday in Scotland, forgetting that the plate ◦ was on the bench and thus not placed in the 37 Cincubator. The weather records for London from 1928 show that the first week of August that year was unusually cold, followed by hot summer weather. Mold cells grow faster than bacteria at low temperatures, which means that a mold colony could have formed during the cold spell, while the staphylococci caught up in the following warm period, then to meet with the penicillin produced and diffused out from the mold, forming the famous zone. This could be looked at as an example of serendipity, a scientist finding something quite significant without having looked for it (Fig. The First Therapeutic Trial Fleming identified the penicillin-producing mold as Penicillium notatum and showed that extracts from cultures of it inhibited the growth of several pathogenic bacterial strains. Fleming left this research after about half a year, however, with a report delivered on May 10, 1929 and published in the June issue of British Journal of Experimental Pathology (No 3, volume 40). In this paper the therapeutic possibilities of penicillin are only mentioned in connection with the treatment of infected wounds. ItisanenigmainthehistoryofmedicinewhyFlem- ing left research on penicillin so quickly. Fleming’s basic observations on penicillin were developed further toward an antibacterial remedy only after a period of 12 years, in 1940. Rediscovery of Penicillin by a Basic Scientific Approach In 1940, Australian-born Howard Florey, a professor of pathol- ogy, German-born Ernst Chain, a biochemist, and British-born Norman Heatley, a biochemist, all three at Oxford, England, began scientific studies on penicillin. Fleming had shown that penicillin interfered with the bacterial cell wall, and the three men wanted to investigate agents that had the ability to dissolve the murein of the cell wall in parallel with the enzyme lysozyme, the mechanism of action of which Florey had just studied. Chain first thought of penicillin as an enzyme, but very soon during purifi- cation, it emerged as a small molecule. It is interesting to note that it was purely a scientific interest in bacterial cell wall degradation that led the three scientists to take up study of the phenomenon discovered by Fleming. The realization of therapeutic possibilities led to what has been called the most important pharmaceutical experiment ever carried out. It began on Saturday morning, May 25, 1940, in Oxford when Howard Florey injected eight laboratory mice intraperitoneally, each with 108 cells of S. One hour later, four of the eight mice were injected subcutaneously with 10 mg of a brown powder dissolved in water. At half past three on Sunday morning, all four of the mice injected with the brown powder solution were healthy and agile, whereas the other four were dead. Heatley was the co-worker who devised a purification method and also the method needed to assay penicillin activity. The penicillin produced quickly performed as a dramatically efficient remedy against bacterial infections. It immediately provided great relief in the treatment of infected war wounds, and very soon it found its way into clinical medicine in general. Alexander Fleming, Howard Florey, and Ernst Chain were awarded the Nobel Prize in Physiology or Medicine in 1945. Today, penicillin is produced in copious amounts all over the world using industrial procedures that are so efficient that the final product is pure enough for direct use in pharmaceutical products. The large global production of penicillin today has led to it being regarded as a commodity on the scale of coffee and tea. Organic chemists have succeeded in the total synthesis of peni- cillin, but industrial production today takes place in large tanks where penicillin-producing mold cells are grown. Betalactams The penicillin isolated originally, penicillin G, is acid labile and has to be administered parenterally lest it be destroyed by stomach acid. One of the first important derivatives of peni- cillin G was phenoxymethylpenicillin (penicillin V), which is acid stable and can be given by mouth. The left part of the figure depicts the relationships among betalactams as a tree with its roots in the penicillin-producing mold Penicillium chrysogenum. The clinical introduction of the various derivatives is given approximately by the time scale to the left. The incite- ment for finding all these betalactams has been both to find antibacterials against pathogens with varying susceptibilities to betalactams, and to counteract the development of resistance (see also Chapter 4). Selman Waks- man at Rutgers University was a well-known expert on soil microbes at the time (Fig. Waksman was particularly inter- ested in the antagonism between microorganisms as a means to understanding how soil microbes interact. In this photograph note the burn hole in the elbow of the lab coat, which is often characteristic of microbiologists, caused by the small, easily overlooked ignition flame of a bunsen burner. He and his co-workers concentrated their search on Actinomyces species and very soon found the two antibacterials actinomycin and streptothricin, which were, however, too toxic for use as antibacterial remedies. Later it was put to good use as a cytostatic agent in the treatment of certain fast-growing forms of cancer, such as the epithelioma of the chorion, and streptothricin has been used for veterinary purposes in some parts of the world. Further research by the group at Rutgers University resulted in the finding of streptomycin, which has been regarded as the second great antibiotic after penicillin. It had a dramatic medical impact because it was the first effective agent against Mycobacterium tuberculosis and thus the first effective remedy for tuberculosis, against which penicillin is not effective. The discovery was published in 1944 in Proceedings of the Society for Experimental Biology and Medicine in a paper, ‘‘Streptomycin: a Substance Exhibiting Antibiotic Activity Against Gram Positive and Gram Negative Bacteria. He had isolated one of the streptomycin-producing strains of Strepto- myces griseus and also tested the effect of this new antibiotic on different bacteria. He would, however, not have been able to do this without access to the expertise on soil microorganisms and the system of methods available in Waksman’s laboratory. The discovery of streptomycin was not at the time regarded as anything genuinely new in the scientific world, but as a devel- opment of concepts formulated in the breakthrough of penicillin as a medicine. Although Albert Schatz was responsible for the actual discovery, he was not included in the prize. This and the substantial amounts of royalty money that the commercial distribution of streptomycin as a pharmaceutical would bring in led to one of the bitterest feuds the world of science has ever seen. It continued for more than two decades, and included lawsuits, most of which Waksman won. The protocols and regulations of the Nobel Committee at the Karolinska Institute are kept confidential for 50 years, so those regarding Waksman are now accessible for scrutiny. The strep- tomycin discovery, particularly with reference to the treatment of tuberculosis, was the subject of several reports and evalua- tions at that time. The most important one was dated August 21, 1952, and was signed by Einar Hammarsten, then professor and head of the Department of Medical and Physiological Chemistry at the Karolinska Institute.

Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillation cordarone 200mg without prescription. Economic justification of the use of dispensing technologies in independent community pharmacies proven 200 mg cordarone. Multimethod evaluation of information and communication technologies in health in the context of wicked problems and sociotechnical theory order 200 mg cordarone fast delivery. Applied strategies for improving patient safety: a comprehensive process to improve care in rural and frontier communities buy cordarone 100 mg fast delivery. Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing. Outpatient management of warfarin therapy: comparison of computer-predicted dosage adjustment to skilled professional care. Prophylactic antibiotic use: hardwiring of physician behavior, not education, leads to compliance. Development and exploitation of a clinical decision support system for the management of renal anaemia. Insulin algorithms in the self-management of insulin-dependent diabetes: the interactive ‘Apple Juice’ program. Minimizing heparin risk: Evaluation of the impact of an automated “clinical rule”. Improving enoxaparin prescribing: Evaluation of the impact of an automated “clinical rule”. Multiple-order intravenous drug management system in a medical/surgical intensive care unit: Opportunities and challenges for pharmacy practice. Computer modelling and microcostin methodologies in preliminary feasibility studies of automated dispensing systems. Implementation and evaluation of a fluoroquinolone formulary change in a large community hospital. A systematic approach: new study looks at what drives top performance in clinical quality, efficiency at systems. Rapid deployment of physician order entry using web-based, disease-specific order sets. Web-based physician order entry: an open source solution with broad physician involvement. Consent and confidentiality: Legal implications of electronic transmission of prescriptions. Patient-perceived usefulness of online electronic medical records: Employing grounded theory in the development of information and communication technologies for use by patients living with chronic illness. Efficacy of order entry warfarin-drug interaction alert systems based on physician responses and patient outcomes in general medicine patients. Impact of a clinical pharmacy consult service on guideline adherence and management of gabapentin for neuropathic pain. Microcomputers for improvement of quality of stock formulations in public pharmacies. Use of electronic reminder devices to improve adherence to antiretroviral therapy: A systematic review. Computerized clinical decision support systems have the potential to detect drug-lab interactions in outpatient clinics. Improving the efficiency of the prescription process and promoting plan adherence. MedSurg Nursing: official journal of the Academy of Medical-Surgical Nurses 2007;16(2):92-100. Multidisciplinary systems approach to chemotherapy safety: rebuilding processes and holding the gains. Two-year follow-up of the computerized physician order entry system compared to the order turn-around time of the paper-based system. An approach to preventing methotrexate prescribing errors in rheumatoid arthritis. Systematic prevention of methotrexate prescribing errors in rheumatoid arthritis patients. Enhancing pharmacy clinical services through the use of an automated drug dispensing system. Redesigning the medication ordering, dispensing, and administration process in an acute care academic health sciences centre. Implementation of an ambulatory medication management application in a pediatric emergency department. Implementation of one way order entry interface between a pharmacy and a nursing computer systems. Technology and intensive management in youth with type 1 diabetes: state of the art. Remote order entry and video verification: Reducing after-hours medication errors in a rural hospital. Involvement in medical informatics may enable pharmacists to expand their consultation potential and improve the quality of healthcare. Improving medication safety with a wireless mobile barcode system in a community hospital. Computerized decision support for intravenous fluid management in pediatric patients. Use of decision support in a computerized prescriber order entry system to prevent medication errors associated with ordering of potassium chloride in a pediatric critical care unit. Designing decision support for insulin ordering in a computerized provider order entry system. Medication adherence among the elderly and technology aids: Results from an online survey study. Testing the technology acceptance model for evaluating healthcare professionals’ intention to use an adverse event reporting system. The next generation of clinical decision support: linking evidence to best practice. Implementation of a computerized physician order entry system of medications at the University Health Network--physicians’ perspectives on the critical issues. Impact of information quality on the use and effectiveness of computerized clinical reminders Purdue Univeristy. Computerized patient management system improves compliance, efficiency and revenue in an anticoagulation clinic. The development and operation of a package inserts service system for electronic medical records. Yakugaku Zasshi - Journal of the Pharmaceutical Society of Japan 2003;123(3):201-9. Construction and evaluation of a cancer chemotherapy regimen database using an electronic medical chart network. Yakugaku Zasshi - Journal of the Pharmaceutical Society of Japan 2005;125(7):567-77. Development of a computerized accounting system for therapeutic drug monitoring [Japanese]. Pediatric and adult emergency management assistance using computerized guidelines. Efficacy of interferon treatment for chronic hepatitis C predicted by feature subset selection and support vector machine. Design and application of drug dispensing software with on­ line drug information. Improving pharmaceutical care in oncology by pharmacoinformatics: the evolving role of informatics and the internet for drug therapy. A computerized system for signal detection in spontaneous reporting system of Shanghai China. Use of a system-wide electronic event reporting system to improve medication safety. Assessment of user satisfaction with an internet-based integrated patient education system for diabetes management. Time motion study in a pediatric emergency department before and after computer physician order entry. Real-time surveillance and decision support: Optimizing infection control and antimicrobial choices at the point of care. Use of computer decision support interventions to improve medication prescribing in older adults: a systematic review.